ZOOMLION (01157) reported net profit attributable to shareholders of approximately RMB2.961 billion for the first three quarters, down 24.46% year on year.
ZOOMLION (01157) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB40.0195 billion, up 7.71% year on year; net profit attributable to shareholders of the listed company of approximately RMB2.961 billion, down 24.46% year on year; and basic earnings per share of RMB0.34.
ZOOMLION (01157) announced its results for the first three quarters of 2026, with operating revenue of approximately RMB40.0195 billion, up 7.71% year on year; net profit attributable to shareholders of the listed company of approximately RMB2.961 billion, down 24.46% year on year; and basic earnings per share of RMB0.34.
Related Articles

SHOUCHENG (00697) repurchased 5.55 million shares on October 29 for HK$6.659 million.

ZERO2IPO (01945) repurchased 2,000 shares on October 29 for HK$2,598.

DAWNRAYS PHARMA (02348) repurchased 44,000 shares for HK$40,500 on October 29.
SHOUCHENG (00697) repurchased 5.55 million shares on October 29 for HK$6.659 million.

ZERO2IPO (01945) repurchased 2,000 shares on October 29 for HK$2,598.

DAWNRAYS PHARMA (02348) repurchased 44,000 shares for HK$40,500 on October 29.






